[对老年人代谢综合征的有效干预:系统性审查和元分析]
Seo-Hyun Lee1, Seul Goo1, Yu-Mi Seo1
1질병관리청 경북권질병대응센터 만성질환조사과.
Jugan geon-gang gwa jilbyeong
|December 3, 2025
概括
在韩国管理代谢综合征.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 韩国正在快速老龄化,管理老年人的代谢综合征的重要性日益增加.
- 代谢综合征是一组增加心脏病,中风和糖尿病风险的疾病,特别是在老年人中.
- 有效的管理策略对于预防这种人口中的慢性疾病至关重要.
研究的目的:
- 系统地审查和对65岁及以上老年人代谢综合征干预计划的国内实验研究进行元分析.
- 确定有效的干预成分和持续时间,以改善老年人群中代谢综合征指标.
主要方法:
- 一个系统的文献综述和对17项干预研究的元分析.
- 分析重点是炼计划和针对代谢综合征指标的复杂干预措施.
- 研究包括65岁及以上的参与者.
主要成果:
- 运动和复杂的干预措施显著改善了主要的代谢综合征指标:血压,中性脂肪,高密度脂蛋白胆固醇,腰围和禁食血糖.
- 与6周的干预相比,超过12周的干预显示出更大的有效性.
- 运动和联合干预措施都对老年人的代谢健康产生了积极影响.
结论:
- 运动和复杂干预是韩国老年人代谢综合征管理的有效策略.
- 建议使用更长的干预时间 (12周以上) 才能获得最佳结果.
- 这项研究为为老年人制定未来基于证据的干预计划提供了基础数据.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Oral Hypoglycemic Agents: Biguanides and Glitazones
565
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
565


